Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.

[1]  Divita Garg,et al.  Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly , 2020, Nature Communications.

[2]  G. Goodall,et al.  RNA in cancer , 2020, Nature reviews. Cancer.

[3]  H. Hara,et al.  Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy , 2020, Scientific Reports.

[4]  M. Cazzola.  Myelodysplastic Syndromes. , 2020, The New England journal of medicine.

[5]  J. M. Suñé-Negre,et al.  Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease , 2020, Frontiers in Genetics.

[6]  E. Buratti,et al.  Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease. , 2020, Journal of biotechnology.

[7]  Young-A. Heo.  Golodirsen: First Approval , 2020, Drugs.

[8]  K. Sobczak,et al.  AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1 , 2020, Nucleic acids research.

[9]  A. Krainer,et al.  SnapShot: Splicing Alterations in Cancer , 2020, Cell.

[10]  Julio Delgado,et al.  The U1 spliceosomal RNA is recurrently mutated in multiple cancers , 2019, Nature.

[11]  John A. Calarco,et al.  Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma , 2019, Nature.

[12]  K. Helin,et al.  PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia , 2019, Nature Structural & Molecular Biology.

[13]  Alexander V Penson,et al.  Spliceosomal disruption of the non-canonical BAF complex in cancer , 2019, Nature.

[14]  Bas J. Wouters,et al.  Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. , 2019, Cancer cell.

[15]  A. Paulussen,et al.  New insights into minor splicing—a transcriptomic analysis of cells derived from TALS patients , 2019, RNA.

[16]  T. Bergauer,et al.  A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier , 2018, British journal of clinical pharmacology.

[17]  Sahar Al Seesi,et al.  Minor spliceosome inactivation causes microcephaly, owing to cell cycle defects and death of self-amplifying radial glial cells , 2018, Development.

[18]  Michael Reutlinger,et al.  Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA). , 2018, Journal of medicinal chemistry.

[19]  A. Ludolph,et al.  Antisense oligonucleotides in neurological disorders , 2018, Therapeutic advances in neurological disorders.

[20]  Peng Yu,et al.  Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome , 2018, Proceedings of the National Academy of Sciences.

[21]  J. Satoh,et al.  Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation , 2018, Scientific Reports.

[22]  S. Takeda,et al.  Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy , 2018, Science Translational Medicine.

[23]  M. Warmuth,et al.  H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers , 2018, Nature Medicine.

[24]  Peter G. Smith,et al.  Targeting splicing abnormalities in cancer. , 2018, Current opinion in genetics & development.

[25]  C. Shao,et al.  The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. , 2018, Molecular cell.

[26]  C. Logan,et al.  The expanding phenotype of RNU4ATAC pathogenic variants to Lowry Wood syndrome , 2018, American journal of medical genetics. Part A.

[27]  I. Eperon,et al.  The mechanisms of a mammalian splicing enhancer , 2018, Nucleic acids research.

[28]  M. Frilander,et al.  Minor spliceosome and disease. , 2017, Seminars in cell & developmental biology.

[29]  Adrian R. Krainer,et al.  Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers , 2017, Nature Communications.

[30]  P. Cortelli,et al.  Messenger RNA processing is altered in autosomal dominant leukodystrophy , 2015, Human molecular genetics.

[31]  E. Androphy,et al.  How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy , 2017, Gene Therapy.

[32]  Margaret A. Goralski,et al.  Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15 , 2017, Science.

[33]  T. Owa,et al.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides. , 2017, Nature chemical biology.

[34]  K. Lim,et al.  Eteplirsen in the treatment of Duchenne muscular dystrophy , 2017, Drug design, development and therapy.

[35]  R. Storb,et al.  RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. , 2016, Cell stem cell.

[36]  Omar Abdel-Wahab,et al.  Therapeutic targeting of splicing in cancer , 2016, Nature Medicine.

[37]  Mallory A. Havens,et al.  Splice-switching antisense oligonucleotides as therapeutic drugs , 2016, Nucleic acids research.

[38]  O. Mühlemann,et al.  Minor intron splicing is regulated by FUS and affected by ALS‐associated FUS mutants , 2016, The EMBO journal.

[39]  D. Garry,et al.  Dystrophin-Deficient Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[40]  F. Metzger,et al.  Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. , 2016, Human molecular genetics.

[41]  M. Swanson,et al.  RNA mis-splicing in disease , 2015, Nature Reviews Genetics.

[42]  Daniele Merico,et al.  Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing , 2015, Nature Communications.

[43]  G. W. Hatfield,et al.  The Silent Sway of Splicing by Synonymous Substitutions* , 2015, The Journal of Biological Chemistry.

[44]  Thomas M. Smith,et al.  SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. , 2015, Nature chemical biology.

[45]  R. Kole,et al.  Exon skipping therapy for Duchenne muscular dystrophy. , 2015, Advanced drug delivery reviews.

[46]  F. Pagani,et al.  Analysis of aberrant pre‐messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA , 2015, Hepatology.

[47]  R. Månsson,et al.  Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia , 2015, Current Allergy and Asthma Reports.

[48]  C. Ho,et al.  LDLR gene synonymous mutation c.1813C>T results in mRNA splicing variation in a kindred with familial hypercholesterolaemia , 2015, Annals of clinical biochemistry.

[49]  Gene W. Yeo,et al.  ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP , 2015, Nature Communications.

[50]  D. Halley,et al.  Identification and Characterization of Aberrant GAA Pre‐mRNA Splicing in Pompe Disease Using a Generic Approach , 2015, Human mutation.

[51]  Anirvan Ghosh,et al.  SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy , 2014, Science.

[52]  L. Pellizzoni,et al.  SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. , 2014, Seminars in cell & developmental biology.

[53]  L. Kunkel,et al.  A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). , 2014, Human molecular genetics.

[54]  Nathalie Jette,et al.  A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy , 2014, Neuromuscular Disorders.

[55]  F. Rigo,et al.  Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides , 2014, Nucleic acids research.

[56]  L. Pérez-Jurado,et al.  Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency , 2014, EMBO molecular medicine.

[57]  T. Révész,et al.  The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons , 2013, Acta Neuropathologica.

[58]  F. J. Ramos,et al.  Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors , 2013, Clinical Cancer Research.

[59]  Jerry R Mendell,et al.  Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy , 2013, Muscle & nerve.

[60]  A. Hinnebusch,et al.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 , 2013, Nature Genetics.

[61]  A. Kakita,et al.  Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. , 2013, Human molecular genetics.

[62]  Z. Tümer.  An Overview and Update of ATP7A Mutations Leading to Menkes Disease and Occipital Horn Syndrome , 2013, Human mutation.

[63]  D. Housman,et al.  Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease , 2013, Proceedings of the National Academy of Sciences.

[64]  A. Bowcock,et al.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma , 2013, Nature Genetics.

[65]  H. Kaufmann,et al.  Familial dysautonomia (Riley–Day syndrome): When baroreceptor feedback fails , 2012, Autonomic Neuroscience.

[66]  Kushol Gupta,et al.  The survival motor neuron protein forms soluble glycine zipper oligomers. , 2012, Structure.

[67]  M. Frilander,et al.  The significant other: splicing by the minor spliceosome , 2012, Wiley interdisciplinary reviews. RNA.

[68]  Zefeng Wang,et al.  Intronic Splicing Enhancers, Cognate Splicing Factors and Context Dependent Regulation Rules , 2012, Nature Structural &Molecular Biology.

[69]  Annemieke Aartsma-Rus,et al.  Long-term Exon Skipping Studies With 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models , 2012, Molecular therapy. Nucleic acids.

[70]  M. Wolfe,et al.  Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing , 2012, Nucleic acids research.

[71]  Y. Hua,et al.  Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing. , 2012, Nature chemical biology.

[72]  P. Ellinor,et al.  RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing , 2012, Nature Medicine.

[73]  F. Allain,et al.  A syn–anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well , 2012, The EMBO journal.

[74]  E. Giné,et al.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.

[75]  Li Ding,et al.  RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES , 2011, Nature Genetics.

[76]  A. Sivachenko,et al.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.

[77]  L. Cartegni,et al.  Antitumorigenic potential of STAT3 alternative splicing modulation , 2011, Proceedings of the National Academy of Sciences.

[78]  M. Stratton,et al.  Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. , 2011, The New England journal of medicine.

[79]  S. Sugano,et al.  Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.

[80]  S. Dimauro,et al.  Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy , 2011, Nature.

[81]  C. Brennan,et al.  Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas , 2011, The EMBO journal.

[82]  J. Kissel,et al.  Spinal muscular atrophy: a timely review. , 2011, Archives of neurology.

[83]  C. Will,et al.  Spliceosome structure and function. , 2011, Cold Spring Harbor perspectives in biology.

[84]  Benjamin J. Raphael,et al.  Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes , 2011, Proceedings of the National Academy of Sciences.

[85]  C. Rivolta,et al.  PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. , 2011, Human molecular genetics.

[86]  R. Kole,et al.  Modulation of RNA splicing as a potential treatment for cancer , 2011, Bioengineered bugs.

[87]  A. Leutenegger,et al.  Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA , 2011, Science.

[88]  Sandya Liyanarachchi,et al.  Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I , 2011, Science.

[89]  Y. Hua,et al.  Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy , 2011, Science Translational Medicine.

[90]  C. Has,et al.  Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa , 2011, Journal of Medical Genetics.

[91]  R. Kole,et al.  Anti-tumor activity of splice-switching oligonucleotides , 2010, Nucleic acids research.

[92]  Y. Hua,et al.  Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. , 2010, Genes & development.

[93]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[94]  Peter J. Shepard,et al.  The SR protein family , 2009, Genome Biology.

[95]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[96]  Akinori Nakamura,et al.  Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs , 2009, Annals of neurology.

[97]  C. Lorson,et al.  Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. , 2009, Human molecular genetics.

[98]  R. Gatti,et al.  Progress toward therapy with antisense-mediated splicing modulation. , 2009, Current opinion in molecular therapeutics.

[99]  R. Kole,et al.  Therapeutic potential of splice-switching oligonucleotides. , 2009, Oligonucleotides.

[100]  S. Riazuddin,et al.  Gene structure and mutant alleles of PCDH15: nonsyndromic deafness DFNB23 and type 1 Usher syndrome , 2008, Human Genetics.

[101]  S. Alves,et al.  Molecular characterization of Portuguese patients with mucopolysaccharidosis IIIC: two novel mutations in the HGSNAT gene , 2008, Clinical genetics.

[102]  M. Holmberg,et al.  Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. , 2008, Human molecular genetics.

[103]  Lili Wan,et al.  SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing , 2008, Cell.

[104]  C. Burge,et al.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. , 2008, RNA.

[105]  Y. Hua,et al.  Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. , 2008, American journal of human genetics.

[106]  Benjamin J. Blencowe,et al.  SnapShot: The Splicing Regulatory Machinery , 2008, Cell.

[107]  Britta Hartmann,et al.  Genome-wide Analysis of Alternative Pre-mRNA Splicing* , 2008, Journal of Biological Chemistry.

[108]  L. Cupples,et al.  A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. , 2007, Human molecular genetics.

[109]  L. D. Schroeder,et al.  Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. , 2007, American journal of human genetics.

[110]  J. Hampe,et al.  Single base‐pair substitutions in exon–intron junctions of human genes: nature, distribution, and consequences for mRNA splicing , 2007, Human mutation.

[111]  T. Meitinger,et al.  Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. , 2006, American journal of human genetics.

[112]  B. Blencowe.  Alternative Splicing: New Insights from Global Analyses , 2006, Cell.

[113]  Zefeng Wang,et al.  General and specific functions of exonic splicing silencers in splicing control. , 2006, Molecular cell.

[114]  W. Foulkes,et al.  A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2. , 2006, The Journal of clinical endocrinology and metabolism.

[115]  M. Claustres,et al.  An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements. , 2006, Human molecular genetics.

[116]  A. Rabinowitz,et al.  Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology , 2006, Nature Medicine.

[117]  E. Androphy,et al.  Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron , 2006, Molecular and Cellular Biology.

[118]  A. Razin,et al.  Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis , 2005, Human Genetics.

[119]  U. Pozzoli,et al.  Silencers regulate both constitutive and alternative splicing events in mammals , 2005, Cellular and Molecular Life Sciences CMLS.

[120]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[121]  U. Monani,et al.  SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. , 2005, Human molecular genetics.

[122]  F. Tezuka,et al.  Electrophysiological and Histopathological Characteristics of Progressive Atrioventricular Block Accompanied by Familial Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene , 2005, Journal of cardiovascular electrophysiology.

[123]  J. Oldenburg,et al.  Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene , 2005, Journal of thrombosis and haemostasis : JTH.

[124]  T. Prior,et al.  Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2 , 2004, American journal of medical genetics. Part A.

[125]  Jeongsik Yong,et al.  Why do cells need an assembly machine for RNA-protein complexes? , 2004, Trends in cell biology.

[126]  Zhi-Ming Zheng,et al.  Regulation of Alternative RNA Splicing by Exon Definition and Exon Sequences in Viral and Mammalian Gene Expression , 2004, Journal of Biomedical Science.

[127]  J. Steitz,et al.  An Intronic Enhancer Regulates Splicing of the Twintron of Drosophila melanogaster prospero Pre-mRNA by Two Different Spliceosomes , 2004, Molecular and Cellular Biology.

[128]  Sherif Abou Elela,et al.  Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides* , 2003, Journal of Biological Chemistry.

[129]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[130]  M. Shaw,et al.  Identification of three novel SEDL mutations, including mutation in the rare, non‐canonical splice site of exon 4 , 2003, Clinical genetics.

[131]  L. Tsui,et al.  Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene. , 2003, Human molecular genetics.

[132]  Laura Scott,et al.  Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.

[133]  F. Muntoni,et al.  Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[134]  T. Cooper,et al.  Finding signals that regulate alternative splicing in the post-genomic era , 2002, Genome Biology.

[135]  Livio Pellizzoni,et al.  Identification and Characterization of Gemin7, a Novel Component of the Survival of Motor Neuron Complex* , 2002, The Journal of Biological Chemistry.

[136]  Phillip A Sharp,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2002, Science.

[137]  K. Imaizumi,et al.  Identification of a Cis-acting Element for the Regulation ofSMN Exon 7 Splicing* , 2002, The Journal of Biological Chemistry.

[138]  Sharlene R. Lim,et al.  Modulation of Survival Motor Neuron Pre-mRNA Splicing by Inhibition of Alternative 3′ Splice Site Pairing* , 2001, The Journal of Biological Chemistry.

[139]  G. Meister,et al.  A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs , 2001, Nature Cell Biology.

[140]  F. Baas,et al.  Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. , 2001, Human molecular genetics.

[141]  C. Will,et al.  Spliceosomal UsnRNP biogenesis, structure and function. , 2001, Current opinion in cell biology.

[142]  E. Bertini,et al.  Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[143]  B. Graveley.  Sorting out the complexity of SR protein functions. , 2000, RNA.

[144]  F. Baas,et al.  Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). , 2000, Human molecular genetics.

[145]  T. Maniatis,et al.  Multiple Distinct Splicing Enhancers in the Protein-Coding Sequences of a Constitutively Spliced Pre-mRNA , 1999, Molecular and Cellular Biology.

[146]  M. Manoharan,et al.  Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. , 1998, Human molecular genetics.

[147]  Marc Fellous,et al.  Donor splice-site mutations in WT1 are responsible for Frasier syndrome , 1997, Nature Genetics.

[148]  R. Padgett,et al.  Terminal intron dinucleotide sequences do not distinguish between U2- and U12-dependent introns. , 1997, Molecular cell.

[149]  G. Dreyfuss,et al.  The SMN–SIP1 Complex Has an Essential Role in Spliceosomal snRNP Biogenesis , 1997, Cell.

[150]  T. Steitz,et al.  Crystal structure of the two RNA binding domains of human hnRNP A1 at 1.75 Å resolution , 1997, Nature Structural Biology.

[151]  Y. Takeshima,et al.  Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. , 1995, The Journal of clinical investigation.

[152]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[153]  A. Thompson,et al.  Splice junction mutations in factor IX gene resulting in severe hemophilia B. , 1991, Nucleic acids research.

[154]  L. Kunkel,et al.  Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy , 1991, Journal of the Neurological Sciences.

[155]  Tom Maniatis,et al.  Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes , 1983, Nature.

[156]  R. Flavell,et al.  β + Thalassemia: Aberrant splicing results from a single point mutation in an intron , 1981, Cell.

[157]  W. Ford Doolittle,et al.  Genes in pieces: were they ever together? , 1978, Nature.

[158]  F. Jakob,et al.  A homozygous intronic branch-point deletion in the ALPL gene causes infantile hypophosphatasia. , 2017, Bone.

[159]  F. Rigo,et al.  Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects. , 2014, Advances in experimental medicine and biology.

[160]  C. Thornton.  Myotonic dystrophy. , 2014, Neurologic clinics.

[161]  P. LoRusso,et al.  A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors , 2013, Investigational New Drugs.

[162]  Anke Busch,et al.  Evolution of SR protein and hnRNP splicing regulatory factors , 2012, Wiley interdisciplinary reviews. RNA.

[163]  G. van Ommen,et al.  Preclinical PK and PD Studies on 2'-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[164]  S. Stamm,et al.  Regulation of alternative splicing by snoRNAs. , 2006, Cold Spring Harbor symposia on quantitative biology.

[165]  Alessandro Stella,et al.  An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites , 2005, Nature Structural &Molecular Biology.

[166]  B. Poll-The,et al.  Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship , 2004, Human Genetics.

[167]  P. E. Becker,et al.  Eine neue x-chromosomale Muskeldystrophie , 2004, Archiv für Psychiatrie und Nervenkrankheiten.

[168]  B. Wirth,et al.  Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2 , 2002, Genetics in Medicine.

[169]  P. E. Becker.  Two families of benign sex-linked recessive muscular dystrophy. , 1962, Revue canadienne de biologie.